A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) plus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) with Poor Prognosis Features
暂无分享,去创建一个
T. Molina | F. Jardin | G. Salles | J. Picquenot | H. Tilly | V. Ribrag | F. Morschhauser | L. Karlin | J. Michot | C. Sarkozy | S. le Gouill | C. Herbaux | S. Dubois | R. Dubois | B. Suttle | Peggy Cullières-Dartigues